Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer

BMC Cancer
Nakarin KitkumthornA Mutirangura

Abstract

The aim of this study was to evaluate epigenetic status of cyclin A1 in human papillomavirus-associated cervical cancer. Y. Tokumaru et al., Cancer Res 64, 5982-7 (Sep 1, 2004)demonstrated in head and neck squamous-cell cancer an inverse correlation between cyclin A1 promoter hypermethylation and TP53 mutation. Human papillomavirus-associated cervical cancer, however, is deprived of TP53 function by a different mechanism. Therefore, it was of interest to investigate the epigenetic alterations during multistep cervical cancer development. In this study, we performed duplex methylation-specific PCR and reverse transcriptase PCR on several cervical cancer cell lines and microdissected cervical cancers. Furthermore, the incidence of cyclin A1 methylation was studied in 43 samples of white blood cells, 25 normal cervices, and 24, 5 and 30 human papillomavirus-associated premalignant, microinvasive and invasive cervical lesions, respectively. We demonstrated cyclin A1 methylation to be commonly found in cervical cancer, both in vitro and in vivo, with its physiological role being to decrease gene expression. More important, this study demonstrated that not only is cyclin A1 promoter hypermethylation strikingly common in cervical canc...Continue Reading

References

Jan 23, 1991·JAMA : the Journal of the American Medical Association·H M BauerM M Manos
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Oct 9, 1998·British Journal of Cancer·A MutiranguraS Niruthisard
Dec 8, 1998·Nature Genetics·D LiuD J Wolgemuth
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P PisaniJ Ferlay
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·S A Maxwell, G E Davis
Mar 13, 2001·BMC Cancer·W PornthanakasemA Mutirangura
Mar 22, 2002·The Lancet Oncology·Alex Ferenczy, Eduardo Franco
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Mar 6, 2003·Human Mutation·Massimo TommasinoIngeborg Zehbe
Jul 23, 2003·Archives of Pathology & Laboratory Medicine·Roger A Hubbard
Mar 30, 2004·Reproduction : the Official Journal of the Society for the Study of Fertility·Tiffany van der MeerWilliam H Colledge
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andreas WidschwendterMartin Widschwendter
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Virote SriuranpongJ Silvio Gutkind
Oct 1, 2004·Molecular and Cellular Biology·Carsten Müller-TidowHubert Serve
Nov 5, 2004·World Journal of Gastroenterology : WJG·Xiao-Li XuJing-De Zhu
Feb 17, 2005·Journal of the National Cancer Institute·Qinghua FengNancy B Kiviat

❮ Previous
Next ❯

Citations

Jun 22, 2010·Archives of Gynecology and Obstetrics·Shuping ZhaoChengquan Zhao
Jul 18, 2009·Purinergic Signalling·Lingyin ZhouGeorge I Gorodeski
Mar 18, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Pattamawadee YanatatsaneejitNakarin Kitkumthorn
Oct 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mariana BraitMohammad Obaidul Hoque
Nov 26, 2008·BMC Medical Genomics·Maté OngenaertEd Schuuring
Feb 5, 2008·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Chi-Shing Cho
Sep 5, 2012·Chinese Journal of Cancer·Hui-Juan Yang
Oct 18, 2011·Journal of Experimental & Clinical Cancer Research : CR·Yi ZhangRui Chen
Feb 6, 2015·BioMed Research International·Bin YangChun-Shan Han
Sep 4, 2012·Clinical Epigenetics·Kathleen P SaavedraJuan Carlos S Roa
Aug 11, 2007·Oral Oncology·Pattamawadee YanatatsaneejitVirote Sriuranpong
Aug 8, 2015·Cancer Science·Kanwalat ChalertpetPattamawadee Yanatatsaneejit
Dec 31, 2010·International Journal of Cancer. Journal International Du Cancer·Renée M OvermeerRenske D M Steenbergen
Oct 2, 2009·International Journal of Cancer. Journal International Du Cancer·Alain C JungBohdan Wasylyk
Nov 5, 2008·Cancer·Martin A WhitesideElizabeth R Unger
Jan 30, 2018·Laboratory Medicine·Vishuda LaengsriPornlada Nuchnoi
Sep 2, 2017·Viruses·David SotoMargaret E McLaughlin-Drubin
May 10, 2019·International Journal of Molecular Sciences·Marta Del PinoJaume Ordi
Feb 21, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jinchuan FangSufang Jin
Jun 4, 2020·Cells·Chameera Ekanayake WeeramangeChamindie Punyadeera
Jun 23, 2020·Oncology Letters·Pattamawadee YanatatsaneejitApiwat Mutirangura
Sep 10, 2014·The International Journal of Biological Markers·Qiangqiang ZuoRenfu Shao
Nov 29, 2017·Molecular and Clinical Oncology·Megumi YanokuraDaisuke Aoki
Oct 9, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Suthipong ChujanApiwat Mutirangura
Nov 6, 2009·Systems Biology in Reproductive Medicine·A ZhoucunYuan Yang
Apr 25, 2019·Journal of Biomedical Science·Sadhana M Gupta, Jayanti Mania-Pramanik
Oct 22, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nan YangG Bea A Wisman
May 12, 2009·Seminars in Cancer Biology·Anita Szalmás, József Kónya

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
hysterectomy
dot blot
dot blots
PCR
electrophoresis
biopsies

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Lee-Wen HuangJiann-Loung Hwang
Molecular and Cellular Biology
Carsten Müller-TidowHubert Serve
International Journal of Cancer. Journal International Du Cancer
Hung-Cheng LaiMu-Hsien Yu
© 2021 Meta ULC. All rights reserved